Ouro Medicines Funding & Investors
San Francisco, CA
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline.
ouromedicines.comTotal Amount Raised: $120,000,000
Ouro Medicines Funding Rounds
Series A
$120,000,000
Series A Investors
New Enterprise Associates (NEA)Norwest Venture PartnersTPGGSKLongRiver InvestmentsUPMCMonograph CapitalBoyu Capital
Funding info provided by Diffbot.